PLK1 and nonpapillary renal cell carcinoma: The role of Plk1 in the aggressiveness of ccRCC was assessed by two strategies: inactivation/downregulation or over-expression of Plk1. Any attempt to stably downregulate or to invalidate Plk1 failed.